Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 10.20% | |
| Drug Manufacturers - General | 33.92% | 15.76% | |
| Healthcare Plans | 13.13% | 0.87% | |
| Medical Devices | 12.14% | 5.31% | |
| Biotechnology | 11.94% | 7.22% | |
| Diagnostics & Research | 10.59% | 2.10% | |
| Medical Instruments & Supplies | 7.64% | 27.11% | |
| Medical Care Facilities | 3.03% | 23.26% | |
| Drug Manufacturers - Specialty & Generic | 2.71% | -0.18% | |
| Medical Distribution | 2.41% | 18.31% | |
| Health Information Services | 2.38% | 29.06% | |
| Pharmaceutical Retailers | 0.12% | -64.09% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 831.54 | 1,002.82 | 11.48% | | | | Buy | |
| 615.81 | 625.10 | 8.24% | | | | Buy | |
| 155.47 | 175.98 | 5.45% | | | | Buy | |
| 199.50 | 211.24 | 5.13% | | | | Buy | |
| 102.92 | 133.43 | 3.79% | | | | Buy | |
| 551.74 | 657.43 | 3.07% | | | | Buy | |
| 116.59 | 130.01 | 2.94% | | | | Buy | |
| 536.45 | 539.24 | 2.78% | | | | Buy | |
| 245.39 | 288.34 | 2.58% | | | | Buy | |
| 325.28 | 334.20 | 2.54% | | | | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 150.18 | 39.816B | 0.09% | | |
| 277.47 | 20.549B | 0.10% | | |
| 104.18 | 7.244B | 0.35% | | |
| 148.85 | 7.086B | 0.45% | | |
| 60.14 | 4.783B | 0.40% | |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 218.33 | 45.697B | 0.30% | | |
| 92.08 | 45.697B | 0.30% | | |
| 138.71 | 20.549B | 0.10% | | |
| 99.90 | 14.589B | 0.80% | | |
| 99.55 | 14.589B | 0.80% | |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
RatingPrice TargetAnalyst Report: Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
RatingPrice TargetAnalyst Report: Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
RatingPrice TargetAnalyst Report: GSK PLC
GSK plc, based in Brentford, UK, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has active research and development programs in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory and infectious diseases, and biopharmaceuticals.
RatingPrice Target




















